Scope Fluidics Spolka Akcyjna (FRA:S84) ROCE %: -30.23% (As of Mar. 2026)


FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
44 GF Score
Price €24.25
GF Value €26.28
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna ROCE %?

Scope Fluidics Spolka Akcyjna FRA:S84 +2.32% 44 ROCE % is -30.23% as of Mar. 2026. GuruFocus rates FRA:S84 with a GF Score™ of 44/100 and a GF Value™ of €26.28. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Scope Fluidics Spolka Akcyjna's annualized ROCE % for the quarter that ended in Mar. 2026 was -30.23%.

Scope Fluidics Spolka Akcyjna  (FRA:S84) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Scope Fluidics Spolka Akcyjna ROCE % Related Terms

Scope Fluidics Spolka Akcyjna ROCE % Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna ROCE % Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.96 216.78 -8.42 66.66 -26.61

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.79 -18.63 -32.43 -38.78 -30.23
FRA:S84
44GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna ROCE % Calculation

Scope Fluidics Spolka Akcyjna's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-10.682/( ( (40.27 - 2.647) + (45.643 - 2.972) )/ 2 )
=-10.682/( (37.623+42.671)/ 2 )
=-10.682/40.147
=-26.61 %

Scope Fluidics Spolka Akcyjna's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-12.424/( ( (45.643 - 2.972) + (42.508 - 2.986) )/ 2 )
=-12.424/( ( 42.671 + 39.522 )/ 2 )
=-12.424/41.0965
=-30.23 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -30.23% mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a ROCE % of -30.23% as of Mar. 2026.
Is Scope Fluidics Spolka Akcyjna's ROCE % too high?
Scope Fluidics Spolka Akcyjna's current ROCE % is -30.23%. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's ROCE % compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's ROCE % of -30.23% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Scope Fluidics Spolka Akcyjna's current ROCE % is -30.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current ROCE % of -30.23%. The stock's GF Value™ is €26.28, compared to a current price of €24.25 — trading 7.7% below its estimated fair value. The current ROCE % is -30.23%. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current ROCE % is -30.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of €24.25 is trading 7.7% below its estimated GF Value™ of €26.28.

Key valuation signals for FRA:S84:

  • ROCE %: -30.23%
  • GF Value™: €26.28 vs. price of €24.25 (7.7% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
44GF Score

Get the complete analysis for FRA:S84

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€24.25
Price
€26.28
GF Value